2Pepine CJ. Ischemic heart disease in women[J]. J Am Coll Cardiol, 2006, 47 (3s1): S1 - S3.
3Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2013 update a report from the American Heart Association[J]. Circulation,2013, 127 (1) : e6 - e245.
5Vittinghoff E, Shlipak M G , Varosy PD, et al. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogent progestin Replacement Study [J]. Ann Int Med, 2003, 138 ( 2): 81 - 89.
6Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6. 8 years of hormone therapy[J]. JAMA, 2002, 288 (1): 49 - 57.
7Rossouw JE,Anderson GL,Prentice RL,et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Womens Health Initiative randomized controlled trial[J]. JAMA,2002,288(3) :321 -333.
9Albarran JW, Clarke BA, Crawford J. 1t was not chest pain really, I cant explain it! 'An exploratory study on the nature of symptoms experienced by women during their myocardial infarction[J]. J Clin Nurs, 2007, 16 (7): 1292 - 1301.
10Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men OJ . JAMA, 2006, 295 (3): 306 -313.
7Show LI,Redberg RF.Coronary disease in women evidence-based diagnosis and treatment.New Jersey Humana Press,2003:129-141.
8Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ).JAMA,2001,285:2486-2497.
